Crescita Therapeutics Inc.
CRRTF
$0.31
-$0.04-10.71%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 546.70K | 576.80K | -649.40K | -115.70K | -759.60K |
| Total Depreciation and Amortization | 278.80K | 255.10K | 246.00K | 260.70K | 228.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -486.40K | -73.70K | -55.70K | 44.30K | 93.80K |
| Change in Net Operating Assets | 512.60K | -760.40K | 101.70K | 793.70K | 747.80K |
| Cash from Operations | 851.60K | -2.20K | -357.40K | 983.00K | 310.90K |
| Capital Expenditure | -596.10K | -122.90K | -46.00K | -252.20K | -610.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 57.20K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -596.10K | -122.90K | -46.00K | -252.20K | -552.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -118.00K | -116.00K | -116.00K | -113.00K | -110.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -121.00K | -59.00K | -43.00K | -77.00K | -117.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -50.00K | -- |
| Cash from Financing | -173.50K | -126.50K | -110.80K | -171.40K | -166.40K |
| Foreign Exchange rate Adjustments | 8.00K | -4.30K | 2.10K | 37.10K | -12.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.00K | -255.90K | -512.10K | 596.50K | -420.80K |